Outcomes with tirofiban versus DAPT
| Outcome | Tirofiban % (95% CI) | I2 | DAPT % (95% CI) | I2 | P Value |
|---|---|---|---|---|---|
| Thromboembolic complications | 3.6 (1.9–5.8) | 33 | 8.5 (4.5–13.0) | 88 | .04 |
| Hemorrhagic complications | 3.5 (1.8–5.6) | 28 | 5.1 (2.6–8.5) | 80 | .371 |
| Perioperative mortality related to antiplatelet medication | 0.8 (0.2–1.6) | 15 | 1.2 (0.7–2.0) | 0 | .412 |
| Good clinical outcomes | 89.0 (74.0–99.0) | 91 | 92.7 (87.1–96.8) | 87 | .589 |